Home » Topics » Regulatory » EMA

EMA
RSS

EMA recommends restricting modafinil use

July 26, 2010

CHMP concludes topical ketoprofen has positive benefit-to-risk balance

July 23, 2010

FDA recommends further naproxcinod trials in complete response letter to NicOx

July 22, 2010

Global registrational trial announced for rFVIIIFc in hemophilia A

July 12, 2010

EMA commences review of rosiglitazone-containing medicines

July 12, 2010

E.C. approves Reyataz capsules for HIV-1 in pediatric patients

July 9, 2010

Chewable Lipitor obtains European approval for use in children

July 8, 2010

EC approves new indication for Orencia in rheumatoid arthritis

July 7, 2010

EMA completes validation of Dyax's MAA for ecallantide

July 7, 2010

Nycomed receives European marketing authorization for roflumilast in COPD

July 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...